FDA Inspection 1222906 — Eurofins Biopharma Product Testing, Denmark A/S
The FDA completed an inspection of Eurofins Biopharma Product Testing, Denmark A/S on May 17, 2023 in Glostrup. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 17, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Glostrup (Denmark)
Additional details
Mutual Recognition Agreement (MRA)